All Companies

LHCongressional Stock Trades

Labcorp Holdings Inc.

Services-Medical Laboratories

Congressional stock trades in Labcorp Holdings Inc. (LH) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

20

Politicians Trading

4

Last Traded

Aug 25, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
April McClain DelaneyDSep 9, 2026Aug 25, 2026Sell$100,001 - $250,000+5.30%
April McClain DelaneyDSep 9, 2026Aug 7, 2026Sell$1,001 - $15,000+11.41%
April McClain DelaneyDSep 9, 2026Aug 6, 2026Sell$1,001 - $15,000+12.34%
April McClain DelaneyDSep 9, 2026Aug 5, 2026Sell$1,001 - $15,000+13.26%
Gilbert Ray Cisneros, Jr.DApr 7, 2025Mar 31, 2025Sell$1,001 - $15,000+52.78%

Price History

About Labcorp Holdings Inc.

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

FAQ

4 members of Congress have disclosed 20 trades in Labcorp Holdings Inc. (LH). Most active: April McClain Delaney (15), Robert Bresnahan (3), Alan Armstrong (1).

Across all disclosures, members of Congress reported 14 purchases and 6 sales of Labcorp Holdings Inc. (LH). The most recent trade was on Aug 25, 2026.

Alan Armstrong disclosed buying Labcorp Holdings Inc. (LH) on Mar 27, 2026, valued at $1,001 - $15,000.

April McClain Delaney disclosed selling Labcorp Holdings Inc. (LH) on Aug 25, 2026, valued at $100,001 - $250,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.